Ticker Hub
RCKT — AI Analysis & Sentiment
3 recent AI-generated analyses for RCKT. Sentiment and confidence insights updated continuously.
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
Rocket Pharmaceuticals' Q1 results show reduced losses and a stronger financial position due to the PRV sale, extending its cash runway significant...
May 8, 2026Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
The sale of a Priority Review Voucher for $180 million provides Rocket Pharmaceuticals with non-dilutive capital, significantly extending its cash ...
Apr 28, 2026Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
FDA approval for KRESLADI™ is a transformative event for Rocket Pharma, validating its gene therapy platform and opening a path to commercial reven...
Mar 27, 2026